Skip to content

The effects of dry needling on clinical parameters of patients with migraine headache: A Randomized Clinical Controlled Trial

The effects of dry needling technique on clinical parameters of patients with migraine headache: A Randomized Clinical Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200215046499N2
Enrollment
40
Registered
2021-12-06
Start date
2022-01-21
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine headache. Migraine

Interventions

Intervention 1: The intervention group: The participants in the intervention group will be treated with routine medications plus dry needling in the upper trapezius muscle during 3 sessions. The inter

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The diagnosis of migraine headache based on the International Headache Society (IHS) criteria: A. At least five attacks fulfilling criteria. B. Headache attacks lasting 4-72 hours. C. Headache has at least two of the following four characteristics: 1. Moderate or severe pain intensity2. Pulsating quality3. Aggravation by routine physical activity 4. Unilateral location D. During headache at least one of the following: 1.Nausea and/or vomiting 2. Photophobia and phonophobia. Confirmation of the presence of active trigger point in the upper trapezius muscle, according to following criteria: Taut band in the upper trapezius muscle, presence of a hypersensitive nodule, and familiar referral pain. Having migraine headache for more than 3 months. Negative Flex -Rot Test

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Headache intensity. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session,30 days after the last session. Method of measurement: Daily Headache Diary form.

Secondary

MeasureTime frame
Headache frequency. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session,30 days after the last session. Method of measurement: Daily headache diary form.;Headache duration. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session,30 days after the last session. Method of measurement: Daily headache diary form.;Drug consumption. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session,30 days after the last session. Method of measurement: Daily headache diary form.;Pressure pain threshold of upper trapezius muscle trigger points. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session. Method of measurement: A digital algometer.;Pain intensity of upper trapezius trigger points. Timepoint: Pre intervention, immediately post treatment, 7 and 14 days after the first session. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHakimeh Adigozali

Tabriz University of Medical Sciences

Adigozalih@tbzmed.ac.ir+98 41 3337 5359

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026